from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2416c/eis

LFCtreatmentdescriptionclass of inhibitor

0.110

Amikacinug/mL Amikacintranslation

3.832

Cap5-10ug/mL Capreomycintranslation

1.292

Rox10-50 ug/mL Roxithromycintranslation

0.660

SM2-5 ug/mL Streptomycintranslation

-0.338

Tet5-10 ug/mL Tetracyclinetranslation

-0.136

Rif0.2-5ug/mL Rifampicintranscription

1.054

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.957

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.727

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.252

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.576

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.517

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.648

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.114

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.351

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.499

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.559

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.272

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.622

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.344

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.419

KCN5-20 ug/mL Potassium cyaniderespiration

-0.545

NaN30.2-2 mM Sodium aziderespiration

-0.267

Nigericin50 uM Nigericinrespiration

0.318

TRC10-150 ug/mL Triclosanrespiration

0.428

TRZ10-25 ug/mL Thioridazinerespiration

1.136

Valinomycin0.5-10 uM Valinomycinrespiration

-1.380

ZnSO42 mM ZnSO4respiration

-0.546

menadione6-10 ug/mL Menadionerespiration

0.009

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.508

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.085

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.665

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.414

NRP_1Non-replicating persistence stage 1dosRassociated

0.048

Amp0.2mg/mL AmpicillincellWall

-0.488

Cephalexin20-100 ug/mL CephalexincellWall

-0.598

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.065

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.335

EMB10-20 ug/mL EthambutolcellWall

-0.928

Eta12-40 ug/mL EthionamidecellWall

-1.343

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.092

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.231

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.098

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.639

BZA0.12 mg/mL BenzamidearomaticAmides

0.617

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.182

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.534

H2O24 mM hydrogen peroxideDNAdamaging

0.388

Levo10 ug/mL LevofloxacinDNAdamaging

0.638

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.860

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.047

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.118

UVUV-irradiationDNAdamaging

0.627

ARP41-4 ug/mL Antitubercular compound ARP4?

0.199

Antimycin12.5-50 ug/mL Antimycin A?

-0.111

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.151

PA_110-50 ug/mL Antitubercular compound PA-1?

0.265

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.731

PA8240.2-2 ug/mL PA-824?

-1.062

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.805

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.124

Verapamil50 uM Verapamil?

0.228

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.039

methoxatin10-20 ug/mL Methoxatin?